Literature DB >> 33511256

Comprehensive Echocardiographic Findings in Critically Ill COVID-19 Patients With or Without Prior Cardiac Disease.

Renuka Jain1, Pedro D Salinas2, Stacie Kroboth3, Abigail Kaminski1, Sarah Roemer1, Ana Cristina Perez Moreno3, Bijoy K Khandheria1.   

Abstract

PURPOSE: Coronavirus disease 2019 (COVID-19) presents with a spectrum of disease severity, the most serious cases requiring intensive care. Echocardiography is a front-line tool in evaluating cardiovascular complications of COVID-19 in the intensive care unit (ICU); we analyzed transthoracic echocardiograms obtained from this patient population with state-of-the-art ultrasound technology.
METHODS: All patients with COVID-19 requiring ICU admission on whom a transthoracic echocardiogram was obtained were included in the study. Focused transthoracic protocols were performed by experienced sonographers. Echocardiographic variables, including speckle-tracking echocardiography, were collected and analyzed. Clinical information was obtained from the electronic medical record. Patients were followed until discharge.
RESULTS: Of 52 total patients (mean age: 59.9 ± 11.6 years), 59.6% were male and 15 (29%) had known prior cardiac disease. Cardiac complications identified on echocardiography were prevalent, occurring in 55.7% of patients. Patients with known prior cardiac disease were more likely to have new or worsening left ventricular dysfunction. Right ventricular dysfunction was the most common abnormality (assessed qualitatively in 18 cases and with advanced echocardiographic methods in 34 cases). Known prior cardiac disease, right ventricular enlargement, and pulmonary hypertension were significantly associated with morbidity and mortality.
CONCLUSIONS: Patients requiring intensive care for COVID-19 face significant morbidity and mortality, and cardiac complications occur in the majority of patients admitted to the ICU with COVID-19. Those with known prior cardiac disease fare worse, and other echocardiographic findings (right ventricular enlargement, pulmonary hypertension) are also associated with worse outcomes. State-of-the-art echocardiography performed by experienced sonographers can be critical to identifying cardiac complications and guiding ICU strategy.
© 2021 Aurora Health Care, Inc.

Entities:  

Keywords:  COVID-19; coronavirus; echocardiography; intensive care unit; left ventricle; right ventricle

Year:  2021        PMID: 33511256      PMCID: PMC7834169          DOI: 10.17294/2330-0698.1791

Source DB:  PubMed          Journal:  J Patient Cent Res Rev        ISSN: 2330-068X


  15 in total

1.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  J Am Soc Echocardiogr       Date:  2015-01       Impact factor: 5.251

2.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.

Authors:  Shaobo Shi; Mu Qin; Bo Shen; Yuli Cai; Tao Liu; Fan Yang; Wei Gong; Xu Liu; Jinjun Liang; Qinyan Zhao; He Huang; Bo Yang; Congxin Huang
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

3.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

Authors:  Riccardo M Inciardi; Laura Lupi; Gregorio Zaccone; Leonardo Italia; Michela Raffo; Daniela Tomasoni; Dario S Cani; Manuel Cerini; Davide Farina; Emanuele Gavazzi; Roberto Maroldi; Marianna Adamo; Enrico Ammirati; Gianfranco Sinagra; Carlo M Lombardi; Marco Metra
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

4.  Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.

Authors:  Riccardo M Inciardi; Marianna Adamo; Laura Lupi; Dario S Cani; Mattia Di Pasquale; Daniela Tomasoni; Leonardo Italia; Gregorio Zaccone; Chiara Tedino; Davide Fabbricatore; Antonio Curnis; Pompilio Faggiano; Elio Gorga; Carlo M Lombardi; Giuseppe Milesi; Enrico Vizzardi; Marco Volpini; Savina Nodari; Claudia Specchia; Roberto Maroldi; Michela Bezzi; Marco Metra
Journal:  Eur Heart J       Date:  2020-05-14       Impact factor: 29.983

5.  First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.

Authors:  Jia-Hui Zeng; Ying-Xia Liu; Jing Yuan; Fu-Xiang Wang; Wei-Bo Wu; Jin-Xiu Li; Li-Fei Wang; Hong Gao; Yao Wang; Chang-Feng Dong; Yi-Jun Li; Xiao-Juan Xie; Cheng Feng; Lei Liu
Journal:  Infection       Date:  2020-04-10       Impact factor: 3.553

6.  Answering to the Call of Critically Ill Patients: Limiting Sonographer Exposure to COVID-19 with Focused Protocols.

Authors:  Abigail Kaminski; Abby Payne; Sarah Roemer; Denise Ignatowski; Bijoy K Khandheria
Journal:  J Am Soc Echocardiogr       Date:  2020-05-12       Impact factor: 5.251

7.  Right Ventricular Dilation in Hospitalized Patients With COVID-19 Infection.

Authors:  Edgar Argulian; Karan Sud; Birgit Vogel; Chandrashekar Bohra; Vaani P Garg; Soheila Talebi; Stamatios Lerakis; Jagat Narula
Journal:  JACC Cardiovasc Imaging       Date:  2020-05-15

8.  Indications for and Findings on Transthoracic Echocardiography in COVID-19.

Authors:  Sneha S Jain; Qi Liu; Jayant Raikhelkar; Justin Fried; Pierre Elias; Timothy J Poterucha; Ersilia M DeFilippis; Hannah Rosenblum; Elizabeth Y Wang; Bjorn Redfors; Kevin Clerkin; Jan M Griffin; Elaine Y Wan; Marwah Abdalla; Natalie A Bello; Rebecca T Hahn; Daichi Shimbo; Shepard D Weiner; Ajay J Kirtane; Susheel K Kodali; Daniel Burkhoff; LeRoy E Rabbani; Allan Schwartz; Martin B Leon; Shunichi Homma; Marco R Di Tullio; Gabriel Sayer; Nir Uriel; D Edmund Anstey
Journal:  J Am Soc Echocardiogr       Date:  2020-06-17       Impact factor: 5.251

9.  Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study.

Authors:  Yishay Szekely; Yael Lichter; Philippe Taieb; Ariel Banai; Aviram Hochstadt; Ilan Merdler; Amir Gal Oz; Ehud Rothschild; Guy Baruch; Yogev Peri; Yaron Arbel; Yan Topilsky
Journal:  Circulation       Date:  2020-05-29       Impact factor: 29.690

10.  Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China.

Authors:  Qing Deng; Bo Hu; Yao Zhang; Hao Wang; Xiaoyang Zhou; Wei Hu; Yuting Cheng; Jie Yan; Haiqin Ping; Qing Zhou
Journal:  Int J Cardiol       Date:  2020-04-08       Impact factor: 4.164

View more
  4 in total

1.  Clinical Characteristics, Risk Factors, and Outcomes Among a Large Midwestern U.S. Cohort of Patients Hospitalized With COVID-19 Prior to Vaccine Availability.

Authors:  Viviana Zlochiver; Ana Cristina Perez Moreno; Michael Peterson; Khalil Odeh; Ashley Mainville; Katherine Busniewski; Jon Wrobel; Mohamed Hommeida; Blair Tilkens; Payal Sharma; Hlu Vang; Sara Walczak; Fekadesilassie Moges; Kritika Garg; A Jamil Tajik; Suhail Q Allaqaband; Tanvir Bajwa; M Fuad Jan
Journal:  J Patient Cent Res Rev       Date:  2022-04-18

2.  Time course of lung ultrasound findings in patients with COVID-19 pneumonia and cardiac dysfunction.

Authors:  Joao Leote; Tiago Judas; Ana Luísa Broa; Miguel Lopes; Francisca Abecasis; Inês Pintassilgo; Afonso Gonçalves; Filipe Gonzalez
Journal:  Ultrasound J       Date:  2022-07-07

3.  COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases.

Authors:  Yuanyuan Zhang; Mingjie Wang; Xian Zhang; Tianxiao Liu; Peter Libby; Guo-Ping Shi
Journal:  Cardiol Discov       Date:  2021-11-22

Review 4.  Echocardiographic assessment of the right ventricle in COVID-19: a systematic review.

Authors:  Simone Ghidini; Alessio Gasperetti; Luigi Biasco; Gregorio Tersalvi; Dario Winterton; Marco Vicenzi; Mattia Busana; Giovanni Pedrazzini
Journal:  Int J Cardiovasc Imaging       Date:  2021-07-22       Impact factor: 2.357

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.